COMPASS Pathways plc
NASDAQCMPS short interest surges 26.5% in one week to 10.8M shares, though availability remains ample at 375%, easing borrow pressure for sellers.
CMPS heads into the week of July 8 with a wave of bullish analyst action reshaping the Street narrative — even as the stock pulls back 8% on the week and earnings loom on July 30. The analyst story is the standout this…
Options traders have turned unanimously bullish on CMPS. The put-call ratio hit 0.12 on June 25 — the lowest on record and a z-score of -2.3 standard deviations below the 20-day mean. For every put traded, eight calls…
Snapshot as of 6 Aug 2026
COMPASS Pathways reported Q1 earnings on May 13 that beat estimates and flagged an accelerated FDA review timeline, delivering a jolt to a stock that had already climbed 69% over the prior month — and leaving a…
COMPASS Pathways reports Q1 2026 results on May 7 after a month that has completely re-priced the stock — and the short-side has scrambled to keep up. Options positioning has actually turned more bullish into the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CMPS — free to start on ORTEX.
Sign up for free →Open CMPS on ORTEX